Jurriaans S - Search Results

1

Head-to-head validation of six immunoassays for SARS-CoV-2 in hospitalized patients.

Zonneveld R, Jurriaans S, van Gool T, Hofstra JJ, Hekker TAM, Defoer P, Broekhuizen-van Haaften PE, Wentink-Bonnema EM, Boonkamp L, Teunissen CE, Heijboer AC, Martens F, de Bree G, van Vugt M, van Houdt R; Amsterdam UMC COVID-19 Biobank. Zonneveld R, et al. Among authors: jurriaans s. J Clin Virol. 2021 Jun;139:104821. doi: 10.1016/j.jcv.2021.104821. Epub 2021 Apr 18. J Clin Virol. 2021. PMID: 33882373 Free PMC article.

2

Cerebrospinal fluid beta2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor alpha receptors before and after treatment with lamivudine plus zidovudine or stavudine.

Enting RH, Foudraine NA, Lange JM, Jurriaans S, van der Poll T, Weverling GJ, Portegies P. Enting RH, et al. Among authors: jurriaans s. J Neuroimmunol. 2000 Jan 24;102(2):216-21. doi: 10.1016/s0165-5728(99)00219-2. J Neuroimmunol. 2000. PMID: 10636491 Clinical Trial.

3

Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations.

Notermans DW, de Wolf F, Oudshoorn P, Cuijpers HT, Pirillo M, Tiller FW, McClernon DR, Prins JM, Lange JM, Danner SA, Goudsmit J, Jurriaans S. Notermans DW, et al. Among authors: jurriaans s. AIDS Res Hum Retroviruses. 2000 Oct 10;16(15):1507-17. doi: 10.1089/088922200750006038. AIDS Res Hum Retroviruses. 2000. PMID: 11054264

4

Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy.

Gisolf EH, van Praag RM, Jurriaans S, Portegies P, Goudsmit J, Danner SA, Lange JM, Prins JM. Gisolf EH, et al. Among authors: jurriaans s. J Acquir Immune Defic Syndr. 2000 Dec 15;25(5):426-33. doi: 10.1097/00042560-200012150-00007. J Acquir Immune Defic Syndr. 2000. PMID: 11141242 Clinical Trial.

5

Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection.

Enting RH, Prins JM, Jurriaans S, Brinkman K, Portegies P, Lange JM. Enting RH, et al. Among authors: jurriaans s. Clin Infect Dis. 2001 Apr 1;32(7):1095-9. doi: 10.1086/319602. Epub 2001 Mar 15. Clin Infect Dis. 2001. PMID: 11264039

6

OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion.

van Praag RM, Prins JM, Roos MT, Schellekens PT, Ten Berge IJ, Yong SL, Schuitemaker H, Eerenberg AJ, Jurriaans S, de Wolf F, Fox CH, Goudsmit J, Miedema F, Lange JM. van Praag RM, et al. Among authors: jurriaans s. J Clin Immunol. 2001 May;21(3):218-26. doi: 10.1023/a:1011091300321. J Clin Immunol. 2001. PMID: 11403229

7

Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1.

van Praag RM, van Heeswijk RP, Jurriaans S, Lange JM, Hoetelmans RM, Prins JM. van Praag RM, et al. Among authors: jurriaans s. Clin Infect Dis. 2001 Oct 15;33(8):e91-2. doi: 10.1086/322682. Epub 2001 Sep 20. Clin Infect Dis. 2001. PMID: 11565093

8

Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapy.

van Praag RM, Wit FW, Jurriaans S, de Wolf F, Prins JM, Lange JM. van Praag RM, et al. Among authors: jurriaans s. AIDS. 2002 Mar 29;16(5):719-25. doi: 10.1097/00002030-200203290-00007. AIDS. 2002. PMID: 11964528

9

Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in the Netherlands.

Nellen JF, Wit FW, De Wolf F, Jurriaans S, Lange JM, Prins JM. Nellen JF, et al. Among authors: jurriaans s. J Acquir Immune Defic Syndr. 2004 Aug 1;36(4):943-50. doi: 10.1097/00126334-200408010-00008. J Acquir Immune Defic Syndr. 2004. PMID: 15220701

10

Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients.

Sankatsing SU, Jurriaans S, van Swieten P, van Leth F, Cornelissen M, Miedema F, Lange JM, Schuitemaker H, Prins JM. Sankatsing SU, et al. Among authors: jurriaans s. AIDS. 2004 Sep 24;18(14):1925-31. doi: 10.1097/00002030-200409240-00008. AIDS. 2004. PMID: 15353978 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page